
94% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
ORIGINAL RESEARCH article
Front. Sleep
Sec. Sleep and Breathing
Volume 4 - 2025 | doi: 10.3389/frsle.2025.1549272
This article is part of the Research Topic Novel technologies in the diagnosis and management of sleep-disordered breathing: Volume III View all 8 articles
The final, formatted version of the article will be published soon.
You have multiple emails registered with Frontiers:
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
LG, KM, LTM, and SDP are employees of Apnimed Inc. AA reports grant support from Somnifix and serves as a consultant for Respicardia, Eli Lilly, Inspire, Cerebra and Apnimed.Apnimed is developing pharmacological treatments for Obstructive Sleep Apnea. AA is also co-inventor of intellectual property pertaining to wearable sleep apnea phenotyping, relevant to the current manuscript, via his Institution. AA's interests were reviewed by Brigham and Women's Hospital and Mass General Brigham in accordance with their institutional policies. SS reports grant support from Apnimed, Prosomnus, and Dynaflex, and has served as a consultant for Apnimed, Nox Medical, Inspire Medical Systems, Eli Lilly, Respicardia, LinguaFlex, and Achaemenid. He receives royalties for intellectual property pertaining to combination pharmacotherapy for sleep apnea via his Institution. He is also co-inventor of intellectual property pertaining to wearable sleep apnea phenotyping, relevant to the current manuscript, also via his Institution. His industry interactions are actively managed by his Institution.
Keywords: Oximetry, Validation, obstructive sleep apnea, wearable, Monitoring
Received: 20 Dec 2024; Accepted: 13 Mar 2025.
Copyright: © 2025 Gell, Mehta, Esmaeili, Taranto-Montemurro, Sands, Pittman and Azarbarzin. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Stephen D Pittman, Apnimed, Cambridge, United States
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Research integrity at Frontiers
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.